 | • レポートコード：MRC2-11QY10668 • 出版社/出版日：QYResearch / 2020年11月25日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、111ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は血栓性血小板減少性紫斑病治療のグローバル市場について調査・分析したレポートです。種類別（カプラシズマブ、紫斑、OMS-721、その他）市場規模、用途別（病院、診療所、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別血栓性血小板減少性紫斑病治療の競争状況、市場シェア ・世界の血栓性血小板減少性紫斑病治療市場：種類別市場規模 2015年-2020年（カプラシズマブ、紫斑、OMS-721、その他） ・世界の血栓性血小板減少性紫斑病治療市場：種類別市場規模予測 2021年-2026年（カプラシズマブ、紫斑、OMS-721、その他） ・世界の血栓性血小板減少性紫斑病治療市場：用途別市場規模 2015年-2020年（病院、診療所、その他） ・世界の血栓性血小板減少性紫斑病治療市場：用途別市場規模予測 2021年-2026年（病院、診療所、その他） ・北米の血栓性血小板減少性紫斑病治療市場分析：米国、カナダ ・ヨーロッパの血栓性血小板減少性紫斑病治療市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの血栓性血小板減少性紫斑病治療市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の血栓性血小板減少性紫斑病治療市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの血栓性血小板減少性紫斑病治療市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Ablynx NV、Biogen Inc、KM Biologics、Lee's Pharmaceutical Holdings Ltd、Omeros Corp、Takeda ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Market Analysis and Insights: Global Thrombotic Thrombocytopenic Purpura Treatment Market
The global Thrombotic Thrombocytopenic Purpura Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Thrombotic Thrombocytopenic Purpura Treatment Scope and Market Size
Thrombotic Thrombocytopenic Purpura Treatment market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Thrombotic Thrombocytopenic Purpura Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Thrombotic Thrombocytopenic Purpura Treatment market is segmented into
Caplacizumab
Purpura
OMS-721
Others
Segment by Application, the Thrombotic Thrombocytopenic Purpura Treatment market is segmented into
Hospital
Clinic
Others
Regional and Country-level Analysis
The Thrombotic Thrombocytopenic Purpura Treatment market is analysed and market size information is provided by regions (countries).
The key regions covered in the Thrombotic Thrombocytopenic Purpura Treatment market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Thrombotic Thrombocytopenic Purpura Treatment Market Share Analysis
Thrombotic Thrombocytopenic Purpura Treatment market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Thrombotic Thrombocytopenic Purpura Treatment business, the date to enter into the Thrombotic Thrombocytopenic Purpura Treatment market, Thrombotic Thrombocytopenic Purpura Treatment product introduction, recent developments, etc.
The major vendors covered:
Ablynx NV
Biogen Inc
KM Biologics
Lee’s Pharmaceutical Holdings Ltd
Omeros Corp
Takeda
…
1 Study Coverage
1.1 Thrombotic Thrombocytopenic Purpura Treatment Product Introduction
1.2 Market Segments
1.3 Key Thrombotic Thrombocytopenic Purpura Treatment Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Thrombotic Thrombocytopenic Purpura Treatment Market Size Growth Rate by Type
1.4.2 Caplacizumab
1.4.3 Purpura
1.4.4 OMS-721
1.4.5 Others
1.5 Market by Application
1.5.1 Global Thrombotic Thrombocytopenic Purpura Treatment Market Size Growth Rate by Application
1.5.2 Hospital
1.5.3 Clinic
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Thrombotic Thrombocytopenic Purpura Treatment Market Size, Estimates and Forecasts
2.1.1 Global Thrombotic Thrombocytopenic Purpura Treatment Revenue 2015-2026
2.1.2 Global Thrombotic Thrombocytopenic Purpura Treatment Sales 2015-2026
2.2 Global Thrombotic Thrombocytopenic Purpura Treatment, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Thrombotic Thrombocytopenic Purpura Treatment Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Thrombotic Thrombocytopenic Purpura Treatment Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Thrombotic Thrombocytopenic Purpura Treatment Competitor Landscape by Players
3.1 Thrombotic Thrombocytopenic Purpura Treatment Sales by Manufacturers
3.1.1 Thrombotic Thrombocytopenic Purpura Treatment Sales by Manufacturers (2015-2020)
3.1.2 Thrombotic Thrombocytopenic Purpura Treatment Sales Market Share by Manufacturers (2015-2020)
3.2 Thrombotic Thrombocytopenic Purpura Treatment Revenue by Manufacturers
3.2.1 Thrombotic Thrombocytopenic Purpura Treatment Revenue by Manufacturers (2015-2020)
3.2.2 Thrombotic Thrombocytopenic Purpura Treatment Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Thrombotic Thrombocytopenic Purpura Treatment Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Thrombotic Thrombocytopenic Purpura Treatment Revenue in 2019
3.2.5 Global Thrombotic Thrombocytopenic Purpura Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Thrombotic Thrombocytopenic Purpura Treatment Price by Manufacturers
3.4 Thrombotic Thrombocytopenic Purpura Treatment Manufacturing Base Distribution, Product Types
3.4.1 Thrombotic Thrombocytopenic Purpura Treatment Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Thrombotic Thrombocytopenic Purpura Treatment Product Type
3.4.3 Date of International Manufacturers Enter into Thrombotic Thrombocytopenic Purpura Treatment Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Thrombotic Thrombocytopenic Purpura Treatment Market Size by Type (2015-2020)
4.1.1 Global Thrombotic Thrombocytopenic Purpura Treatment Sales by Type (2015-2020)
4.1.2 Global Thrombotic Thrombocytopenic Purpura Treatment Revenue by Type (2015-2020)
4.1.3 Thrombotic Thrombocytopenic Purpura Treatment Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Thrombotic Thrombocytopenic Purpura Treatment Market Size Forecast by Type (2021-2026)
4.2.1 Global Thrombotic Thrombocytopenic Purpura Treatment Sales Forecast by Type (2021-2026)
4.2.2 Global Thrombotic Thrombocytopenic Purpura Treatment Revenue Forecast by Type (2021-2026)
4.2.3 Thrombotic Thrombocytopenic Purpura Treatment Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Thrombotic Thrombocytopenic Purpura Treatment Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Thrombotic Thrombocytopenic Purpura Treatment Market Size by Application (2015-2020)
5.1.1 Global Thrombotic Thrombocytopenic Purpura Treatment Sales by Application (2015-2020)
5.1.2 Global Thrombotic Thrombocytopenic Purpura Treatment Revenue by Application (2015-2020)
5.1.3 Thrombotic Thrombocytopenic Purpura Treatment Price by Application (2015-2020)
5.2 Thrombotic Thrombocytopenic Purpura Treatment Market Size Forecast by Application (2021-2026)
5.2.1 Global Thrombotic Thrombocytopenic Purpura Treatment Sales Forecast by Application (2021-2026)
5.2.2 Global Thrombotic Thrombocytopenic Purpura Treatment Revenue Forecast by Application (2021-2026)
5.2.3 Global Thrombotic Thrombocytopenic Purpura Treatment Price Forecast by Application (2021-2026)
6 North America
6.1 North America Thrombotic Thrombocytopenic Purpura Treatment by Country
6.1.1 North America Thrombotic Thrombocytopenic Purpura Treatment Sales by Country
6.1.2 North America Thrombotic Thrombocytopenic Purpura Treatment Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Thrombotic Thrombocytopenic Purpura Treatment Market Facts & Figures by Type
6.3 North America Thrombotic Thrombocytopenic Purpura Treatment Market Facts & Figures by Application
7 Europe
7.1 Europe Thrombotic Thrombocytopenic Purpura Treatment by Country
7.1.1 Europe Thrombotic Thrombocytopenic Purpura Treatment Sales by Country
7.1.2 Europe Thrombotic Thrombocytopenic Purpura Treatment Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Thrombotic Thrombocytopenic Purpura Treatment Market Facts & Figures by Type
7.3 Europe Thrombotic Thrombocytopenic Purpura Treatment Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Thrombotic Thrombocytopenic Purpura Treatment by Region
8.1.1 Asia Pacific Thrombotic Thrombocytopenic Purpura Treatment Sales by Region
8.1.2 Asia Pacific Thrombotic Thrombocytopenic Purpura Treatment Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Thrombotic Thrombocytopenic Purpura Treatment Market Facts & Figures by Type
8.3 Asia Pacific Thrombotic Thrombocytopenic Purpura Treatment Market Facts & Figures by Application
9 Latin America
9.1 Latin America Thrombotic Thrombocytopenic Purpura Treatment by Country
9.1.1 Latin America Thrombotic Thrombocytopenic Purpura Treatment Sales by Country
9.1.2 Latin America Thrombotic Thrombocytopenic Purpura Treatment Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Thrombotic Thrombocytopenic Purpura Treatment Market Facts & Figures by Type
9.3 Central & South America Thrombotic Thrombocytopenic Purpura Treatment Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Thrombotic Thrombocytopenic Purpura Treatment by Country
10.1.1 Middle East and Africa Thrombotic Thrombocytopenic Purpura Treatment Sales by Country
10.1.2 Middle East and Africa Thrombotic Thrombocytopenic Purpura Treatment Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Thrombotic Thrombocytopenic Purpura Treatment Market Facts & Figures by Type
10.3 Middle East and Africa Thrombotic Thrombocytopenic Purpura Treatment Market Facts & Figures by Application
11 Company Profiles
11.1 Ablynx NV
11.1.1 Ablynx NV Corporation Information
11.1.2 Ablynx NV Description and Business Overview
11.1.3 Ablynx NV Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Ablynx NV Thrombotic Thrombocytopenic Purpura Treatment Products Offered
11.1.5 Ablynx NV Related Developments
11.2 Biogen Inc
11.2.1 Biogen Inc Corporation Information
11.2.2 Biogen Inc Description and Business Overview
11.2.3 Biogen Inc Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Biogen Inc Thrombotic Thrombocytopenic Purpura Treatment Products Offered
11.2.5 Biogen Inc Related Developments
11.3 KM Biologics
11.3.1 KM Biologics Corporation Information
11.3.2 KM Biologics Description and Business Overview
11.3.3 KM Biologics Sales, Revenue and Gross Margin (2015-2020)
11.3.4 KM Biologics Thrombotic Thrombocytopenic Purpura Treatment Products Offered
11.3.5 KM Biologics Related Developments
11.4 Lee’s Pharmaceutical Holdings Ltd
11.4.1 Lee’s Pharmaceutical Holdings Ltd Corporation Information
11.4.2 Lee’s Pharmaceutical Holdings Ltd Description and Business Overview
11.4.3 Lee’s Pharmaceutical Holdings Ltd Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Lee’s Pharmaceutical Holdings Ltd Thrombotic Thrombocytopenic Purpura Treatment Products Offered
11.4.5 Lee’s Pharmaceutical Holdings Ltd Related Developments
11.5 Omeros Corp
11.5.1 Omeros Corp Corporation Information
11.5.2 Omeros Corp Description and Business Overview
11.5.3 Omeros Corp Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Omeros Corp Thrombotic Thrombocytopenic Purpura Treatment Products Offered
11.5.5 Omeros Corp Related Developments
11.6 Takeda
11.6.1 Takeda Corporation Information
11.6.2 Takeda Description and Business Overview
11.6.3 Takeda Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Takeda Thrombotic Thrombocytopenic Purpura Treatment Products Offered
11.6.5 Takeda Related Developments
11.1 Ablynx NV
11.1.1 Ablynx NV Corporation Information
11.1.2 Ablynx NV Description and Business Overview
11.1.3 Ablynx NV Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Ablynx NV Thrombotic Thrombocytopenic Purpura Treatment Products Offered
11.1.5 Ablynx NV Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Thrombotic Thrombocytopenic Purpura Treatment Market Estimates and Projections by Region
12.1.1 Global Thrombotic Thrombocytopenic Purpura Treatment Sales Forecast by Regions 2021-2026
12.1.2 Global Thrombotic Thrombocytopenic Purpura Treatment Revenue Forecast by Regions 2021-2026
12.2 North America Thrombotic Thrombocytopenic Purpura Treatment Market Size Forecast (2021-2026)
12.2.1 North America: Thrombotic Thrombocytopenic Purpura Treatment Sales Forecast (2021-2026)
12.2.2 North America: Thrombotic Thrombocytopenic Purpura Treatment Revenue Forecast (2021-2026)
12.2.3 North America: Thrombotic Thrombocytopenic Purpura Treatment Market Size Forecast by Country (2021-2026)
12.3 Europe Thrombotic Thrombocytopenic Purpura Treatment Market Size Forecast (2021-2026)
12.3.1 Europe: Thrombotic Thrombocytopenic Purpura Treatment Sales Forecast (2021-2026)
12.3.2 Europe: Thrombotic Thrombocytopenic Purpura Treatment Revenue Forecast (2021-2026)
12.3.3 Europe: Thrombotic Thrombocytopenic Purpura Treatment Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Thrombotic Thrombocytopenic Purpura Treatment Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Thrombotic Thrombocytopenic Purpura Treatment Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Thrombotic Thrombocytopenic Purpura Treatment Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Thrombotic Thrombocytopenic Purpura Treatment Market Size Forecast by Region (2021-2026)
12.5 Latin America Thrombotic Thrombocytopenic Purpura Treatment Market Size Forecast (2021-2026)
12.5.1 Latin America: Thrombotic Thrombocytopenic Purpura Treatment Sales Forecast (2021-2026)
12.5.2 Latin America: Thrombotic Thrombocytopenic Purpura Treatment Revenue Forecast (2021-2026)
12.5.3 Latin America: Thrombotic Thrombocytopenic Purpura Treatment Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Thrombotic Thrombocytopenic Purpura Treatment Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Thrombotic Thrombocytopenic Purpura Treatment Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Thrombotic Thrombocytopenic Purpura Treatment Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Thrombotic Thrombocytopenic Purpura Treatment Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Thrombotic Thrombocytopenic Purpura Treatment Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Thrombotic Thrombocytopenic Purpura Treatment Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Thrombotic Thrombocytopenic Purpura Treatment Market Segments
Table 2. Ranking of Global Top Thrombotic Thrombocytopenic Purpura Treatment Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Thrombotic Thrombocytopenic Purpura Treatment Market Size Growth Rate by Type 2020-2026 (MT) & (US$ Million)
Table 4. Major Manufacturers of Caplacizumab
Table 5. Major Manufacturers of Purpura
Table 6. Major Manufacturers of OMS-721
Table 7. Major Manufacturers of Others
Table 8. Global Thrombotic Thrombocytopenic Purpura Treatment Market Size Growth Rate by Application 2020-2026 (MT)
Table 9. Global Thrombotic Thrombocytopenic Purpura Treatment Market Size by Region (MT) & (US$ Million): 2020 VS 2026
Table 10. Global Thrombotic Thrombocytopenic Purpura Treatment Sales by Regions 2015-2020 (MT)
Table 11. Global Thrombotic Thrombocytopenic Purpura Treatment Sales Market Share by Regions (2015-2020)
Table 12. Global Thrombotic Thrombocytopenic Purpura Treatment Revenue by Regions 2015-2020 (US$ Million)
Table 13. Global Thrombotic Thrombocytopenic Purpura Treatment Sales by Manufacturers (2015-2020) (MT)
Table 14. Global Thrombotic Thrombocytopenic Purpura Treatment Sales Share by Manufacturers (2015-2020)
Table 15. Global Thrombotic Thrombocytopenic Purpura Treatment Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 16. Global Thrombotic Thrombocytopenic Purpura Treatment by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Thrombotic Thrombocytopenic Purpura Treatment as of 2019)
Table 17. Thrombotic Thrombocytopenic Purpura Treatment Revenue by Manufacturers (2015-2020) (US$ Million)
Table 18. Thrombotic Thrombocytopenic Purpura Treatment Revenue Share by Manufacturers (2015-2020)
Table 19. Key Manufacturers Thrombotic Thrombocytopenic Purpura Treatment Price (2015-2020) (USD/Kg)
Table 20. Thrombotic Thrombocytopenic Purpura Treatment Manufacturers Manufacturing Base Distribution and Headquarters
Table 21. Manufacturers Thrombotic Thrombocytopenic Purpura Treatment Product Type
Table 22. Date of International Manufacturers Enter into Thrombotic Thrombocytopenic Purpura Treatment Market
Table 23. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 24. Global Thrombotic Thrombocytopenic Purpura Treatment Sales by Type (2015-2020) (MT)
Table 25. Global Thrombotic Thrombocytopenic Purpura Treatment Sales Share by Type (2015-2020)
Table 26. Global Thrombotic Thrombocytopenic Purpura Treatment Revenue by Type (2015-2020) (US$ Million)
Table 27. Global Thrombotic Thrombocytopenic Purpura Treatment Revenue Share by Type (2015-2020)
Table 28. Thrombotic Thrombocytopenic Purpura Treatment Average Selling Price (ASP) by Type 2015-2020 (USD/Kg)
Table 29. Global Thrombotic Thrombocytopenic Purpura Treatment Sales by Application (2015-2020) (MT)
Table 30. Global Thrombotic Thrombocytopenic Purpura Treatment Sales Share by Application (2015-2020)
Table 31. North America Thrombotic Thrombocytopenic Purpura Treatment Sales by Country (2015-2020) (MT)
Table 32. North America Thrombotic Thrombocytopenic Purpura Treatment Sales Market Share by Country (2015-2020)
Table 33. North America Thrombotic Thrombocytopenic Purpura Treatment Revenue by Country (2015-2020) (US$ Million)
Table 34. North America Thrombotic Thrombocytopenic Purpura Treatment Revenue Market Share by Country (2015-2020)
Table 35. North America Thrombotic Thrombocytopenic Purpura Treatment Sales by Type (2015-2020) (MT)
Table 36. North America Thrombotic Thrombocytopenic Purpura Treatment Sales Market Share by Type (2015-2020)
Table 37. North America Thrombotic Thrombocytopenic Purpura Treatment Sales by Application (2015-2020) (MT)
Table 38. North America Thrombotic Thrombocytopenic Purpura Treatment Sales Market Share by Application (2015-2020)
Table 39. Europe Thrombotic Thrombocytopenic Purpura Treatment Sales by Country (2015-2020) (MT)
Table 40. Europe Thrombotic Thrombocytopenic Purpura Treatment Sales Market Share by Country (2015-2020)
Table 41. Europe Thrombotic Thrombocytopenic Purpura Treatment Revenue by Country (2015-2020) (US$ Million)
Table 42. Europe Thrombotic Thrombocytopenic Purpura Treatment Revenue Market Share by Country (2015-2020)
Table 43. Europe Thrombotic Thrombocytopenic Purpura Treatment Sales by Type (2015-2020) (MT)
Table 44. Europe Thrombotic Thrombocytopenic Purpura Treatment Sales Market Share by Type (2015-2020)
Table 45. Europe Thrombotic Thrombocytopenic Purpura Treatment Sales by Application (2015-2020) (MT)
Table 46. Europe Thrombotic Thrombocytopenic Purpura Treatment Sales Market Share by Application (2015-2020)
Table 47. Asia Pacific Thrombotic Thrombocytopenic Purpura Treatment Sales by Region (2015-2020) (MT)
Table 48. Asia Pacific Thrombotic Thrombocytopenic Purpura Treatment Sales Market Share by Region (2015-2020)
Table 49. Asia Pacific Thrombotic Thrombocytopenic Purpura Treatment Revenue by Region (2015-2020) (US$ Million)
Table 50. Asia Pacific Thrombotic Thrombocytopenic Purpura Treatment Revenue Market Share by Region (2015-2020)
Table 51. Asia Pacific Thrombotic Thrombocytopenic Purpura Treatment Sales by Type (2015-2020) (MT)
Table 52. Asia Pacific Thrombotic Thrombocytopenic Purpura Treatment Sales Market Share by Type (2015-2020)
Table 53. Asia Pacific Thrombotic Thrombocytopenic Purpura Treatment Sales by Application (2015-2020) (MT)
Table 54. Asia Pacific Thrombotic Thrombocytopenic Purpura Treatment Sales Market Share by Application (2015-2020)
Table 55. Latin America Thrombotic Thrombocytopenic Purpura Treatment Sales by Country (2015-2020) (MT)
Table 56. Latin America Thrombotic Thrombocytopenic Purpura Treatment Sales Market Share by Country (2015-2020)
Table 57. Latin Americaa Thrombotic Thrombocytopenic Purpura Treatment Revenue by Country (2015-2020) (US$ Million)
Table 58. Latin America Thrombotic Thrombocytopenic Purpura Treatment Revenue Market Share by Country (2015-2020)
Table 59. Latin America Thrombotic Thrombocytopenic Purpura Treatment Sales by Type (2015-2020) (MT)
Table 60. Latin America Thrombotic Thrombocytopenic Purpura Treatment Sales Market Share by Type (2015-2020)
Table 61. Latin America Thrombotic Thrombocytopenic Purpura Treatment Sales by Application (2015-2020) (MT)
Table 62. Latin America Thrombotic Thrombocytopenic Purpura Treatment Sales Market Share by Application (2015-2020)
Table 63. Middle East and Africa Thrombotic Thrombocytopenic Purpura Treatment Sales by Country (2015-2020) (MT)
Table 64. Middle East and Africa Thrombotic Thrombocytopenic Purpura Treatment Sales Market Share by Country (2015-2020)
Table 65. Middle East and Africa Thrombotic Thrombocytopenic Purpura Treatment Revenue by Country (2015-2020) (US$ Million)
Table 66. Middle East and Africa Thrombotic Thrombocytopenic Purpura Treatment Revenue Market Share by Country (2015-2020)
Table 67. Middle East and Africa Thrombotic Thrombocytopenic Purpura Treatment Sales by Type (2015-2020) (MT)
Table 68. Middle East and Africa Thrombotic Thrombocytopenic Purpura Treatment Sales Market Share by Type (2015-2020)
Table 69. Middle East and Africa Thrombotic Thrombocytopenic Purpura Treatment Sales by Application (2015-2020) (MT)
Table 70. Middle East and Africa Thrombotic Thrombocytopenic Purpura Treatment Sales Market Share by Application (2015-2020)
Table 71. Ablynx NV Corporation Information
Table 72. Ablynx NV Description and Major Businesses
Table 73. Ablynx NV Thrombotic Thrombocytopenic Purpura Treatment Production (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 74. Ablynx NV Product
Table 75. Ablynx NV Recent Development
Table 76. Biogen Inc Corporation Information
Table 77. Biogen Inc Description and Major Businesses
Table 78. Biogen Inc Thrombotic Thrombocytopenic Purpura Treatment Production (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 79. Biogen Inc Product
Table 80. Biogen Inc Recent Development
Table 81. KM Biologics Corporation Information
Table 82. KM Biologics Description and Major Businesses
Table 83. KM Biologics Thrombotic Thrombocytopenic Purpura Treatment Production (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 84. KM Biologics Product
Table 85. KM Biologics Recent Development
Table 86. Lee's Pharmaceutical Holdings Ltd Corporation Information
Table 87. Lee's Pharmaceutical Holdings Ltd Description and Major Businesses
Table 88. Lee's Pharmaceutical Holdings Ltd Thrombotic Thrombocytopenic Purpura Treatment Production (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 89. Lee's Pharmaceutical Holdings Ltd Product
Table 90. Lee's Pharmaceutical Holdings Ltd Recent Development
Table 91. Omeros Corp Corporation Information
Table 92. Omeros Corp Description and Major Businesses
Table 93. Omeros Corp Thrombotic Thrombocytopenic Purpura Treatment Production (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 94. Omeros Corp Product
Table 95. Omeros Corp Recent Development
Table 96. Takeda Corporation Information
Table 97. Takeda Description and Major Businesses
Table 98. Takeda Thrombotic Thrombocytopenic Purpura Treatment Production (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 99. Takeda Product
Table 100. Takeda Recent Development
Table 101. Global Thrombotic Thrombocytopenic Purpura Treatment Sales Forecast by Regions (2021-2026) (MT)
Table 102. Global Thrombotic Thrombocytopenic Purpura Treatment Sales Market Share Forecast by Regions (2021-2026)
Table 103. Global Thrombotic Thrombocytopenic Purpura Treatment Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 104. Global Thrombotic Thrombocytopenic Purpura Treatment Revenue Market Share Forecast by Regions (2021-2026)
Table 105. North America: Thrombotic Thrombocytopenic Purpura Treatment Sales Forecast by Country (2021-2026) (MT)
Table 106. North America: Thrombotic Thrombocytopenic Purpura Treatment Revenue Forecast by Country (2021-2026) (US$ Million)
Table 107. Europe: Thrombotic Thrombocytopenic Purpura Treatment Sales Forecast by Country (2021-2026) (MT)
Table 108. Europe: Thrombotic Thrombocytopenic Purpura Treatment Revenue Forecast by Country (2021-2026) (US$ Million)
Table 109. Asia Pacific: Thrombotic Thrombocytopenic Purpura Treatment Sales Forecast by Region (2021-2026) (MT)
Table 110. Asia Pacific: Thrombotic Thrombocytopenic Purpura Treatment Revenue Forecast by Region (2021-2026) (US$ Million)
Table 111. Latin America: Thrombotic Thrombocytopenic Purpura Treatment Sales Forecast by Country (2021-2026) (MT)
Table 112. Latin America: Thrombotic Thrombocytopenic Purpura Treatment Revenue Forecast by Country (2021-2026) (US$ Million)
Table 113. Middle East and Africa: Thrombotic Thrombocytopenic Purpura Treatment Sales Forecast by Country (2021-2026) (MT)
Table 114. Middle East and Africa: Thrombotic Thrombocytopenic Purpura Treatment Revenue Forecast by Country (2021-2026) (US$ Million)
Table 115. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 116. Key Challenges
Table 117. Market Risks
Table 118. Main Points Interviewed from Key Thrombotic Thrombocytopenic Purpura Treatment Players
Table 119. Thrombotic Thrombocytopenic Purpura Treatment Customers List
Table 120. Thrombotic Thrombocytopenic Purpura Treatment Distributors List
Table 121. Research Programs/Design for This Report
Table 122. Key Data Information from Secondary Sources
Table 123. Key Data Information from Primary Sources
List of Figures
Figure 1. Thrombotic Thrombocytopenic Purpura Treatment Product Picture
Figure 2. Global Thrombotic Thrombocytopenic Purpura Treatment Sales Market Share by Type in 2020 & 2026
Figure 3. Caplacizumab Product Picture
Figure 4. Purpura Product Picture
Figure 5. OMS-721 Product Picture
Figure 6. Others Product Picture
Figure 7. Global Thrombotic Thrombocytopenic Purpura Treatment Sales Market Share by Application in 2020 & 2026
Figure 8. Hospital
Figure 9. Clinic
Figure 10. Others
Figure 11. Thrombotic Thrombocytopenic Purpura Treatment Report Years Considered
Figure 12. Global Thrombotic Thrombocytopenic Purpura Treatment Market Size 2015-2026 (US$ Million)
Figure 13. Global Thrombotic Thrombocytopenic Purpura Treatment Sales 2015-2026 (MT)
Figure 14. Global Thrombotic Thrombocytopenic Purpura Treatment Market Size Market Share by Region: 2020 Versus 2026
Figure 15. Global Thrombotic Thrombocytopenic Purpura Treatment Sales Market Share by Region (2015-2020)
Figure 16. Global Thrombotic Thrombocytopenic Purpura Treatment Sales Market Share by Region in 2019
Figure 17. Global Thrombotic Thrombocytopenic Purpura Treatment Revenue Market Share by Region (2015-2020)
Figure 18. Global Thrombotic Thrombocytopenic Purpura Treatment Revenue Market Share by Region in 2019
Figure 19. Global Thrombotic Thrombocytopenic Purpura Treatment Sales Share by Manufacturer in 2019
Figure 20. The Top 10 and 5 Players Market Share by Thrombotic Thrombocytopenic Purpura Treatment Revenue in 2019
Figure 21. Thrombotic Thrombocytopenic Purpura Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 22. Global Thrombotic Thrombocytopenic Purpura Treatment Sales Market Share by Type (2015-2020)
Figure 23. Global Thrombotic Thrombocytopenic Purpura Treatment Sales Market Share by Type in 2019
Figure 24. Global Thrombotic Thrombocytopenic Purpura Treatment Revenue Market Share by Type (2015-2020)
Figure 25. Global Thrombotic Thrombocytopenic Purpura Treatment Revenue Market Share by Type in 2019
Figure 26. Global Thrombotic Thrombocytopenic Purpura Treatment Market Share by Price Range (2015-2020)
Figure 27. Global Thrombotic Thrombocytopenic Purpura Treatment Sales Market Share by Application (2015-2020)
Figure 28. Global Thrombotic Thrombocytopenic Purpura Treatment Sales Market Share by Application in 2019
Figure 29. Global Thrombotic Thrombocytopenic Purpura Treatment Revenue Market Share by Application (2015-2020)
Figure 30. Global Thrombotic Thrombocytopenic Purpura Treatment Revenue Market Share by Application in 2019
Figure 31. North America Thrombotic Thrombocytopenic Purpura Treatment Sales Growth Rate 2015-2020 (MT)
Figure 32. North America Thrombotic Thrombocytopenic Purpura Treatment Revenue Growth Rate 2015-2020 (US$ Million)
Figure 33. North America Thrombotic Thrombocytopenic Purpura Treatment Sales Market Share by Country in 2019
Figure 34. North America Thrombotic Thrombocytopenic Purpura Treatment Revenue Market Share by Country in 2019
Figure 35. U.S. Thrombotic Thrombocytopenic Purpura Treatment Sales Growth Rate (2015-2020) (MT)
Figure 36. U.S. Thrombotic Thrombocytopenic Purpura Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 37. Canada Thrombotic Thrombocytopenic Purpura Treatment Sales Growth Rate (2015-2020) (MT)
Figure 38. Canada Thrombotic Thrombocytopenic Purpura Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 39. North America Thrombotic Thrombocytopenic Purpura Treatment Market Share by Type in 2019
Figure 40. North America Thrombotic Thrombocytopenic Purpura Treatment Market Share by Application in 2019
Figure 41. Europe Thrombotic Thrombocytopenic Purpura Treatment Sales Growth Rate 2015-2020 (MT)
Figure 42. Europe Thrombotic Thrombocytopenic Purpura Treatment Revenue Growth Rate 2015-2020 (US$ Million)
Figure 43. Europe Thrombotic Thrombocytopenic Purpura Treatment Sales Market Share by Country in 2019
Figure 44. Europe Thrombotic Thrombocytopenic Purpura Treatment Revenue Market Share by Country in 2019
Figure 45. Germany Thrombotic Thrombocytopenic Purpura Treatment Sales Growth Rate (2015-2020) (MT)
Figure 46. Germany Thrombotic Thrombocytopenic Purpura Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 47. France Thrombotic Thrombocytopenic Purpura Treatment Sales Growth Rate (2015-2020) (MT)
Figure 48. France Thrombotic Thrombocytopenic Purpura Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. U.K. Thrombotic Thrombocytopenic Purpura Treatment Sales Growth Rate (2015-2020) (MT)
Figure 50. U.K. Thrombotic Thrombocytopenic Purpura Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. Italy Thrombotic Thrombocytopenic Purpura Treatment Sales Growth Rate (2015-2020) (MT)
Figure 52. Italy Thrombotic Thrombocytopenic Purpura Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Russia Thrombotic Thrombocytopenic Purpura Treatment Sales Growth Rate (2015-2020) (MT)
Figure 54. Russia Thrombotic Thrombocytopenic Purpura Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 55. Europe Thrombotic Thrombocytopenic Purpura Treatment Market Share by Type in 2019
Figure 56. Europe Thrombotic Thrombocytopenic Purpura Treatment Market Share by Application in 2019
Figure 57. Asia Pacific Thrombotic Thrombocytopenic Purpura Treatment Sales Growth Rate 2015-2020 (MT)
Figure 58. Asia Pacific Thrombotic Thrombocytopenic Purpura Treatment Revenue Growth Rate 2015-2020 (US$ Million)
Figure 59. Asia Pacific Thrombotic Thrombocytopenic Purpura Treatment Sales Market Share by Region in 2019
Figure 60. Asia Pacific Thrombotic Thrombocytopenic Purpura Treatment Revenue Market Share by Region in 2019
Figure 61. China Thrombotic Thrombocytopenic Purpura Treatment Sales Growth Rate (2015-2020) (MT)
Figure 62. China Thrombotic Thrombocytopenic Purpura Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 63. Japan Thrombotic Thrombocytopenic Purpura Treatment Sales Growth Rate (2015-2020) (MT)
Figure 64. Japan Thrombotic Thrombocytopenic Purpura Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. South Korea Thrombotic Thrombocytopenic Purpura Treatment Sales Growth Rate (2015-2020) (MT)
Figure 66. South Korea Thrombotic Thrombocytopenic Purpura Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. India Thrombotic Thrombocytopenic Purpura Treatment Sales Growth Rate (2015-2020) (MT)
Figure 68. India Thrombotic Thrombocytopenic Purpura Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. Australia Thrombotic Thrombocytopenic Purpura Treatment Sales Growth Rate (2015-2020) (MT)
Figure 70. Australia Thrombotic Thrombocytopenic Purpura Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Taiwan Thrombotic Thrombocytopenic Purpura Treatment Sales Growth Rate (2015-2020) (MT)
Figure 72. Taiwan Thrombotic Thrombocytopenic Purpura Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Indonesia Thrombotic Thrombocytopenic Purpura Treatment Sales Growth Rate (2015-2020) (MT)
Figure 74. Indonesia Thrombotic Thrombocytopenic Purpura Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Thailand Thrombotic Thrombocytopenic Purpura Treatment Sales Growth Rate (2015-2020) (MT)
Figure 76. Thailand Thrombotic Thrombocytopenic Purpura Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Malaysia Thrombotic Thrombocytopenic Purpura Treatment Sales Growth Rate (2015-2020) (MT)
Figure 78. Malaysia Thrombotic Thrombocytopenic Purpura Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Philippines Thrombotic Thrombocytopenic Purpura Treatment Sales Growth Rate (2015-2020) (MT)
Figure 80. Philippines Thrombotic Thrombocytopenic Purpura Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Vietnam Thrombotic Thrombocytopenic Purpura Treatment Sales Growth Rate (2015-2020) (MT)
Figure 82. Vietnam Thrombotic Thrombocytopenic Purpura Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 83. Asia Pacific Thrombotic Thrombocytopenic Purpura Treatment Market Share by Type in 2019
Figure 84. Asia Pacific Thrombotic Thrombocytopenic Purpura Treatment Market Share by Application in 2019
Figure 85. Latin America Thrombotic Thrombocytopenic Purpura Treatment Sales Growth Rate 2015-2020 (MT)
Figure 86. Latin America Thrombotic Thrombocytopenic Purpura Treatment Revenue Growth Rate 2015-2020 (US$ Million)
Figure 87. Latin America Thrombotic Thrombocytopenic Purpura Treatment Sales Market Share by Country in 2019
Figure 88. Latin America Thrombotic Thrombocytopenic Purpura Treatment Revenue Market Share by Country in 2019
Figure 89. Mexico Thrombotic Thrombocytopenic Purpura Treatment Sales Growth Rate (2015-2020) (MT)
Figure 90. Mexico Thrombotic Thrombocytopenic Purpura Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 91. Brazil Thrombotic Thrombocytopenic Purpura Treatment Sales Growth Rate (2015-2020) (MT)
Figure 92. Brazil Thrombotic Thrombocytopenic Purpura Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 93. Argentina Thrombotic Thrombocytopenic Purpura Treatment Sales Growth Rate (2015-2020) (MT)
Figure 94. Argentina Thrombotic Thrombocytopenic Purpura Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 95. Latin America Thrombotic Thrombocytopenic Purpura Treatment Market Share by Type in 2019
Figure 96. Latin America Thrombotic Thrombocytopenic Purpura Treatment Market Share by Application in 2019
Figure 97. Middle East and Africa Thrombotic Thrombocytopenic Purpura Treatment Sales Growth Rate 2015-2020 (MT)
Figure 98. Middle East and Africa Thrombotic Thrombocytopenic Purpura Treatment Revenue Growth Rate 2015-2020 (US$ Million)
Figure 99. Middle East and Africa Thrombotic Thrombocytopenic Purpura Treatment Sales Market Share by Country in 2019
Figure 100. Middle East and Africa Thrombotic Thrombocytopenic Purpura Treatment Revenue Market Share by Country in 2019
Figure 101. Turkey Thrombotic Thrombocytopenic Purpura Treatment Sales Growth Rate (2015-2020) (MT)
Figure 102. Turkey Thrombotic Thrombocytopenic Purpura Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 103. Saudi Arabia Thrombotic Thrombocytopenic Purpura Treatment Sales Growth Rate (2015-2020) (MT)
Figure 104. Saudi Arabia Thrombotic Thrombocytopenic Purpura Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 105. U.A.E Thrombotic Thrombocytopenic Purpura Treatment Sales Growth Rate (2015-2020) (MT)
Figure 106. U.A.E Thrombotic Thrombocytopenic Purpura Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 107. Middle East and Africa Thrombotic Thrombocytopenic Purpura Treatment Market Share by Type in 2019
Figure 108. Middle East and Africa Thrombotic Thrombocytopenic Purpura Treatment Market Share by Application in 2019
Figure 109. North America Thrombotic Thrombocytopenic Purpura Treatment Sales Growth Rate Forecast (2021-2026) (MT)
Figure 110. North America Thrombotic Thrombocytopenic Purpura Treatment Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 111. Europe Thrombotic Thrombocytopenic Purpura Treatment Sales Growth Rate Forecast (2021-2026) (MT)
Figure 112. Europe Thrombotic Thrombocytopenic Purpura Treatment Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 113. Asia Pacific Thrombotic Thrombocytopenic Purpura Treatment Sales Growth Rate Forecast (2021-2026) (MT)
Figure 114. Asia Pacific Thrombotic Thrombocytopenic Purpura Treatment Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 115. Latin America Thrombotic Thrombocytopenic Purpura Treatment Sales Growth Rate Forecast (2021-2026) (MT)
Figure 116. Latin America Thrombotic Thrombocytopenic Purpura Treatment Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 117. Middle East and Africa Thrombotic Thrombocytopenic Purpura Treatment Sales Growth Rate Forecast (2021-2026) (MT)
Figure 118. Middle East and Africa Thrombotic Thrombocytopenic Purpura Treatment Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 119. Porter's Five Forces Analysis
Figure 120. Channels of Distribution
Figure 121. Distributors Profiles
Figure 122. Bottom-up and Top-down Approaches for This Report
Figure 123. Data Triangulation
Figure 124. Key Executives Interviewed
特発性血小板減少性紫斑病（ITP）治療薬の世界市場（～2026年） ITP (idiopathic thrombocytopenic purpura) is a rare disease with low affliction rates. This disease leads to excessive bruising or bleeding due to the lack of blood platelets. It is also known as immune thrombocytopenia and can affect children and adults alike. Increasing demand for combination ther…- 紫斑治療の世界市場（～2026年） Purpura is a condition of red or purple discolored spots on the skin that do not blanch on applying pressure. The globally market for purpura treatment is one of the steady growing markets. Purpura occurs when the blood vessels and blood pools under the human skin, result in purple spots on the skin…
- 免疫性血小板減少性紫斑病治療薬の世界市場（～2026年） Market Analysis and Insights: Global Immune Thrombocytopenic Purpura Therapeutics Market The global Immune Thrombocytopenic Purpura Therapeutics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Immune Thrombocytopenic P…
- 血小板・血漿の世界市場（～2026年） Platelets, also called thrombocytes, are a component of blood whose function (along with the coagulation factors) is to react to bleeding from blood vessel injury by clumping, thereby initiating a blood clot. Plasma is a yellowish coloured liquid component of blood that normally holds the blood cell…
- 軟骨無形成症治療の世界市場（～2026年） Market Analysis and Insights: Global Achondroplasia Treatment Market The global Achondroplasia Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Achondroplasia Treatment Scope and Market Size Achondroplasia Tre…